KRT18 and Hepatic steatosis: Recently, a specific byproduct of apoptosis in hepatocytes, caspase-generated cytokeratin-18 (CK-18) fragments, has been shown to be significantly elevated in patients with NASH compared with subjects with fatty liver or healthy controls, with an AUC of 0.93 for predicting NASH [78].